Cardinal's pharmaceutical and specialty solutions segment distributes branded, generic, and specialty drugs and over-the-counter healthcare and consumer products. Cardinal plays a central role in the ...

Cardinal Health reported an increase in revenue for two of its segments, while the departure of Optimum impacted its Pharmaceuticals segment.

Jan. 29, Marist University celebrated their official designation change, along with a new logo and commercial. Here's what to know.

Cardinal Health (CAH) came out with quarterly earnings of $1.93 per share, beating the Zacks Consensus Estimate of $1.75 per share. This compares to earnings of $1.82 per share a year ago. These ...

Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast as strong demand for costly specialty medicines and branded drugs drove sales at its pharmaceuticals unit.

Cardinal Health Inc (CAH) revealed a profit for its second quarter that increased from last year and beat the Street estimates. The ...

Reports Q2 revenue $55.26B, consensus $54.97B. “We delivered strong second quarter financial results while taking significant strategic and ...

Cardinal expects full-year earnings to be $7.85 to $8 per share. Cardinal shares have climbed 8% since the beginning of the year, while the S&P's 500 index has climbed 27%. The stock has risen 20% in ...

Cardinal Health Inc. closed 2.50% below its 52-week high of $131.00, which the company reached on January 27th.

William H. Sanders, the 11th president of Rochester Institute of Technology, answers 11 questions about his personal and ...

Cardinal Health Inc. hit a new 52-week high, surpassing its previous peak of $129.68, which the company achieved on January ...